Genetic contribution of the endothelial nitric oxide synthase gene to high altitude adaptation in Sherpas

High Altitude Medicine and Biology

Volumn 7, Issue 3, 2006, Pages 209-220

  Droma, Yunden ^a   Hanaoka, Masayuki ^a   Basnyat, Buddha ^b,c   Arjyal, Amit ^c   Neupane, Pritam ^c   Pandit, Anil ^c   Sharma, Dependra ^c   Miwa, Naoyuki ^a   Ito, Michiko ^a   Katsuyama, Yoshihiko ^d   Ota, Masao ^a   Kubo, Keishi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NEPAL INTERNATIONAL CLINIC   (Nepal)

^c Mountain Medicine Society of Nepal   (Nepal)

^d SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Association; eNOS gene; Hypoxia; Nitric oxide metabolites (NOx); Polymorphisms; Population

Indexed keywords

ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; ALLELE; ALTITUDE ACCLIMATIZATION; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD ANALYSIS; CIGARETTE SMOKING; CONTROLLED STUDY; EVOLUTIONARY ADAPTATION; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN EXPERIMENT; MALE; METABOLITE; NEPAL; PHENOTYPIC VARIATION; POPULATION GENETICS; PRIORITY JOURNAL; RANDOM SAMPLE; RELIABILITY; WILD TYPE;

ACCLIMATIZATION; ADULT; ALTITUDE; ALTITUDE SICKNESS; ANOXIA; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NEPAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 33846493086     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2006.7.209     Document Type: Article

References (43)

1. Ahsan A., Norboo T., Baig M.A., and Pasha M.A.Q. (2005). Simultaneous selection of the wild-type genotypes of the G894T and 4B/4A polymorphisms of NOS3 associates with high-altitude adaptation. Ann. Hum. Genet. 69:260-267.
2. Association of Domestic Tour Operators of India. (2005). Ladakh, the land of endless discoveries. Available at . Accessed September, 2005.
3. Bangham C.R., and Howarth S.E. (1980). Genetic polymorphisms in isolated Sherpa populations of Nepal. Am. J. Phys. Anthropol. 53:369-373.
4. Beall C.M. (2003). High-altitude adaptations. Lancet 362:S14-S15.
5. Beall C.M., Laskowski D., Strohl K.P., Soria R., Villena M., Vargas E., Alarcon A.M., Gonzales C., and Erzurum S.C. (2001). Pulmonary nitric oxide in mountain dwellers. Nature. 414:411-412.
6. Benjafield A.V., and Morris B.J. (2000). Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am. J. Hypertens. 13:994-998.
7. Boehnke M. (2000). A look at linkage disequilibrium. Nat. Genet. 25:246-247.
8. Cardon L.R., and Palmer L.J. (2003). Population stratification and spurious allelic association. Lancet 361:598-604.
9. Chauhan V., Breznan D., Goegan P., Nadeau D., Karthikeyan S., Brook J.R., and Vincent R. (2004). Effects of ambient air particles on nitric oxide production in macrophage cell lines. Cell Biol. Toxicol. 20:221-239.
10. Droma Y., Hanaoka M., Ota M., Katsuyama Y., Koizumi T., Fujimoto K., Kobayashi T., and Kubo K. (2002). Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation. 106:826-830.
11. Eaves I.A., Merriman T.R., Barber R.A., Nutland S., Tuomilehto-Wolf E., Tuomilehto J., Cucca F., and Todd J.A. (2000). The genetically isolated populations of Finland and Sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nat. Genet. 25:320-323.
12. Fisher J.F. (1997). Sherpas: Reflections on Change in Himalayan Nepal. Oxford University Press, Oxford India Paperbacks, India.
13. Garrido E., Segura R., Capdevila A., Pujol J., Javierre C., and Ventura J.L. (1996). Are Himalayan Sherpas better protected against brain damage associated with extreme altitude climbs? Clin. Sci. (Lond.) 90:81-85.
14. 15N-nitrate in biological fluids. Anal. Biochem. 126:131-138.
15. Groves B.M., Droma T., Sutton J.R., McCullough R.G., McCullough R.E., Zhuang J., Rapmund G., Sun S., Janes C., and Moore L.G. (1993). Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658 m. J. Appl. Physiol. 74:312-318.
16. 31P magnetic resonance spectroscopy of the Sherpa heart: a phosphocreatine/adenosine triphosphate signature of metabolic defense against hypobaric hypoxia. Proc. Natl. Acad. Sci. 93:1215-1220.
17. Holden J.E., Stone C.K., Clark C.M., Brown W.D., Nickles R.J., Stanley C., and Hochachka P.W. (1995). Enhanced cardiac metabolism of plasma glucose in high-altitude natives: adaptation against chronic hypoxia. J. Appl. Physiol. 79:222-228.
18. Inoko H., Ando A., Ito M., and Tsuji K. (1986). Southern hybridization analysis of DNA polymorphism in the HLA-D region. Hum. Immunol. 16:304-313.
19. Jeerooburkhan N., Jones L.C., Bujac S., Cooper J.A., Miller G. J., Vallance P., Humphries S.E., and Hingorani A.D. (2001). Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease. Hypertension. 38:1054-1061.
20. Jorde L.B., and Wooding S.P. (2004). Genetic variation, classification and 'race.' Nat. Genet. 36:S28-S33.
21. Klatzel F. (2000). Stories and Customs of the Sherpas: As Told by Ngawang Tenzin Zangbu, Abbot of Thengboche Monastery. Mera Publications, Kathmandu, Nepal.
22. Maeda S., Miyauchi T., Kakiyama T., Sugawara J., Iemitsu M., Irukayama-Tomobe Y., Murakami H., Kumagai Y., Kuno S., and Matsuda M. (2001). Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans. Life Sci. 69:1005-1016.
23. Marletta, M. A. (1994). Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78:927-930.
24. Marsden P.A., Heng H.H.Q., Scherer S.W., Stewart R.J., Hall A.V., Shi X.M., Tsui L.C., and Schappert K.T. (1993). Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268:17478-17488.
25. Moon J., Yoon S., Kim E., Shin C., Jo S.A., and Jo I. (2002). Lack of evidence for contribution of Glu298Asp (G894T) polymorphism of endothelial nitric oxide synthase gene to plasma nitric oxide levels. Thromb. Res. 107:129-134.
26. Moore L.G. (2001). Human genetic adaptation to high altitude. High Alt. Med. Biol. 2:257-279.
27. Morpurgo G., Arese P., Bosia A., Pescarmona G.P., Luzzana M., Modiano G., and Krishna Ranjit S. (1976). Sherpas living permanently at high altitude: a new pattern of adaptation. Proc. Natl. Acad. Sci. 73:747-751.
28. Niermeyer S., Yang P., Shanmina., Drolkar., Zhuang J., and Moore L.G.. (1995). Arterial oxygen saturation in Tibetan and Han infants born in Lhasa, Tibet. N. Engl. J. Med. 333:1248-1252.
29. Ortner S. Sherpas Through Their Ritual. (1986). Cambridge University Press, Cambridge, England.
30. Santachiara-Benerecetti A.S., Baur E.W., Beretta M., Ranzani G., Morpurgo G., Carter N.D., D'Udine B., Ranjit S.K., and Modiano G.. (1976). A study of several genetic biochemical markers in Sherpas with description of some variant phenotypes. Hum. Hered. 26:51-359.
31. Santolaya R.B., Lahiri S., Alfaro R.T., and Schoene R.B. (1989). Respiratory adaptation in the highest inhabitants and highest Sherpa mountaineers. Respir. Physiol. 77:253-262.
32. Tammen H., Schulte I., Hess R., Menzel C., Kellmann M., Mohring T., and Schulz-Knappe P. (2005). Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics 5:3414-3422.
33. Tesauro M., Thompson W.C., Rogliani R., Qi L., Chaudhary P.P., and Moss J. (2000). Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl. Acad. Sci. U.S.A. 97:2832-2835.
34. Van Amsterdam J.G., Verlaan B.P., Van Loveren H., Elzakker B.G., Vos S.G., Opperhuizen A., and Steerenberg P.A. (1999). Air pollution is associated with increased level of exhaled nitric oxide in nonsmoking healthy subjects. Arch. Environ. Health 54:331-335.
35. Wang J., Felux D., Vandeberg J., and Wang X.L. (2003). Discordance of endothelial nitric oxide synthase in the arterial wall and its circulating products in baboons: interactions with redox metabolism. Eur. J. Clin. Invest. 33:288-295.
36. Wang X.L., Mahaney M.C., Sim A.S., Wang J., Blangero J., Almasy L., Badenhop R.B., and Wilcken D.E. (1997). Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide. Arterioscl. Thromb. Vasc. Biol. 17:3147-3153.
37. Wang X.L., Sim A.S., Badenhop R.F., and McCredie R.M. (1996). A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 2:41-45.
38. Wang X.L., Sim A.S, Wang M.X., Murrell G.A.C., Trudinger B., and Wang J. (2000a). Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FASEB Letters. 471:45-50.
39. Wang X.L., and Wang J. (2000b). Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Gene. Metab. 70:241-251.
40. Wolff B., Grabe H.J., Schluter C., Popowski K., Volzke H., Ludemann J., John U., Felix S.B., and Cascorbi I. (2005). Endothelial nitric oxide synthase Glu298Asp gene polymorphism, blood pressure and hypertension in a general population sample. J. Hypertens. 23:1361-1366.
41. World Medical Association Declaration of Helsinki. (1997). Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 277:925-926.
42. Yoon S., Moon J., Shin C., Kim E., Jo S.A, and Jo I. (2002). Smoking status-dependent association of the 27-bp repeat polymorphism in intron 4 of endothelial nitric oxide synthase gene with plasma nitric oxide concentrations. Clin. Chim. Acta. 324:113-120.
43. Yoon Y., Song J., Hong S.H., and Kim J.Q. (2000). Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin. Chem. 46:1626-1630.